New funding for 香港六合彩中特网 cancer centres announced

20 December 2016

The 香港六合彩中特网 Cancer Research UK Centre, led by Professors Daniel Hochhauser and Henning Walczak, and 香港六合彩中特网's Experimental Cancer Medicine Centre (ECMC), led by Professors Tim Meyer and John Hartley, have successfully secured new funding as part of a 拢226 million UK investment announced by Cancer Research UK.聽

Cancer Research UK Centres bring together research teams from universities, research institutions and NHS hospitals to focuses on translational research 鈥� getting cutting edge discoveries from the laboratory to patients and learning as much as possible from patients to initiate new research ideas and programmes.

One of 13 Cancer Research UK Centres, the 香港六合彩中特网 Centre provides crucial support for translational cancer research and training at 香港六合彩中特网 and its partner clinical institutions including 香港六合彩中特网H, the Royal Free and Great Ormond Street Hospital. The renewed funding reflects 香港六合彩中特网's leading reputation and expertise in advancing world-class cancer research and clinical studies.聽

香港六合彩中特网's Experimental Cancer Medicine Centre (ECMC) is one of 18 centres that form a UK-wide network that drives the discovery, development and testing of new anti-cancer treatments for patients - funded by Cancer Research UK and Departments of Health.聽

香港六合彩中特网 ECMC collaborates with centres across the ECMC network and throughout 香港六合彩中特网 and it's partner hospitals to progress clinical cancer research. The Centre supports a dedicated Clinical Research Facility (CRF) based at 香港六合彩中特网H where a medical team work together on a wide range of early phase clinical trials.聽

Further information

Related news

Cancer Research UK-香港六合彩中特网 Centre receives 拢4m Accelerator Award

Cancer Research UK is investing 拢16m in four UK-wide collaborations to inspire new approaches to understanding and treating cancers with low survival. 聽The Cancer Research UK-香港六合彩中特网 Centre will receive 拢4 million to roll out a national post-mortem tissue bank from patients with hard to treat and metastatic cancer.